Cash-strapped biotech firm Codiak files for bankruptcy protection
Codiak BioSciences Inc said on Monday it has filed for U.S. bankruptcy protection in the latest blow to the struggling drug developer's ambitions of making a COVID-19 vaccine.
United Kingdom Bhanvi Satija Sriparna Roy Shounak Dasgupta Thomson Reuters Trust Principles Codiak Biosciences Inc
Source: reuters.com